Lip inflammation may be generalized, or localized to one or more ulcers or lesions. Although some swelling may be present, the main manifestation is discomfort. Lip swelling with little or no discomfort is discussed elsewhere.
(See also Evaluation of the Dental Patient.)
Lip ulcers and other changes
A number of infectious, neoplastic, or other disorders can cause lip ulcers, growths, and other changes:
Herpes labialis (recurrent herpes simplex virus infection1).
Erythema multiforme: Multiple bullae that rupture quickly and leave crusting hemorrhagic ulcers on labial mucosa. This ulcerative mucocutaneous condition is an immune reaction usually triggered by herpes simplex virus. Erythema multiforme has a variety of appearances and often causes painful oral mucositis. Lip ulcerations are managed with topical corticosteroids or systemic corticosteroids.
Primary syphilis (chancre): A painless ulcer with hard edges. Oral chancres are commonly seen on lips (upper lip more common in males; lower lip more common in females). Treatment of choice for syphilis is penicillin.
Actinic keratosis: Irregular pale, red, or variably colored dry and scaly precancerous growths. This common premalignant condition is caused by chronic exposure to ultraviolet light. Treatments include reducing sun exposure (using sunscreens, wearing hats with wide brims) and laser ablation.
Erythroplakia or leukoplakia: Red or white patches. These patches may be associated with dysplasia and squamous cell carcinoma.
Oral squamous cell carcinoma: May present variably as a hyperkeratotic nodule or plaque, ulcer with hard edges, or as erythroplakia or leukoplakia (particularly early cases that have not ulcerated). Treatment depends on clinical staging at diagnosis and includes wide surgical excision, radiation therapy, or both.
Peutz-Jeghers syndrome: Autosomal dominant condition that includes benign hyperpigmented (dark blue, brown, black) macules of skin and mucosa (especially lip and buccal mucosae), gastrointestinal hamartomatous polyps, and (unrelated to the macules and polyps) predisposition to various cancers.
Cheilitis (lip inflammation)
Cheilitis is acute or chronic inflammation of the lips. It may be caused by infection, sun damage, medications or irritants, allergy, or underlying disease. Inflammation primarily affects the vermilion and vermilion border. Swelling, redness, and pain of the lips occurs; other changes may include cracks, fissures, erosions, crusts, and scale.
Angular cheilitis (angular stomatitis) is the most common form; inflammation, crusting, painful fissures, and often maceration develop in the corners of the mouth. Typical causes include
Excessively worn teeth or dentures that do not adequately separate the jaws, creating skin folds at the corners of the mouth in which saliva accumulates
Candida species (or sometimes Staphylococcus aureus)
Iron deficiency, vitamin B complex deficiency (especially , cobalamin)
© Springer Science+Business Media
Other causes of cheilitis include
Actinic atrophy: Sun damage causing thin, atrophic mucosa with erosions; predisposes to malignancy
Eczematous cheilitis: Red, dry lips (sometimes termed chapped lips) typically caused by contact irritants or sometimes by allergens or as part of atopic dermatitis
Rare types of cheilitis include cheilitis glandularis, cheilitis granulomatosa, and plasma cell cheilitis. Children with Kawasaki disease may develop erythematous, dry, swollen, and cracked lips, along with strawberry tongue.
Diagnosis is usually based on history and inspection. Actinic cheilitis with signs of progression (induration, ulceration, thickening) should be biopsied to rule out carcinoma.
Treatment includes petrolatum or other emollients, as well as elimination or treatment of specific causes. For severe nonmalignant actinic cheilitis, vermilionectomy (lip shave) or CO2 laser ablation may be considered. Sun damage to the lips can be minimized through the use of protective coverings such as a wide-brimmed hat and lip balm containing topical sunscreen.
General reference
1. Spruance SL, Jones TM, Blatter MM, et alAntimicrob Agents Chemother 47(3):1072-1080, 2003. doi: 10.1128/AAC.47.3.1072-1080.2003